Literature DB >> 26187654

PTHrP-Induced Refractory Malignant Hypercalcemia in a Patient With Chronic Lymphocytic Leukemia Responding to Denosumab.

Ameen A Salahudeen1, Arjun Gupta1, Jeremy C Jones1, Robert W Cowan2, Madhuri Vusirikala3, Chi Kwong4, Harris V K Naina5.   

Abstract

Entities:  

Keywords:  CLL; Denosumab; Humoral hypercalcemia; Hypercalcemia of malignancy; PTHrP; Parathyroid hormone–related protein

Mesh：

Substances：

Year:  2015        PMID： 26187654     DOI： 10.1016/j.clml.2015.06.007

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  3 in total

1.  Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.

Authors:  Elena Chertok Shacham; Dafna Chap Marshak; Shay Brikman; Guy Dori; Avraham Ishay
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

2.  Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma.

Authors:  Jeffrey M Kroopnick; Ubaldo Martinez-Outschoorn; Madalina Tuluc; Caroline S Kim
Journal:  AACE Clin Case Rep       Date:  2021-01-19

3.  Renal involvement in chronic lymphocytic leukemia.

Authors:  Rimda Wanchoo; Carolina Bernabe Ramirez; Jacqueline Barrientos; Kenar D Jhaveri
Journal:  Clin Kidney J       Date:  2018-04-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.